Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Men Against the Beast from Patient-passive to Patient-active Prostate Cancer Intervention
THE DREAD:  Prostate Cancer in the U.S.A. <ul><li>Affects aproximately 10 million men </li></ul><ul><li>179,300 new cases ...
Consequences of Treatment: <ul><li>Impotence </li></ul><ul><li>Incontinence </li></ul><ul><li>Loss of Libido </li></ul>
PCa organizations <ul><li>1987: American Foundation for Urologic Disease </li></ul><ul><li>1990: US-TOO </li></ul><ul><li>...
 
Mortality by type of Cancer and Age <ul><li>Yearly rate per 100.000 persons </li></ul>
Prostate and Breast Cancer Mortality by Year <ul><li>Yearly rate per 100.000 persons </li></ul>
Prostate and Breast Cancer Mortality by Race <ul><li>Yearly rate per 100.000 persons </li></ul>
Impotence Research <ul><li>1982: International Society for Impotence Research </li></ul><ul><li>1989: International Meetin...
Scientific Meetings on Prostate Cancer
NCI Appropriations 1980-1999
Compare:  NCI Research dollars by type of cancer
Cancer is incurable, but avoidable  Cancer is inevitable,  but treatable/curable  Prevention So let’s work in   So let’s w...
 
 
 
 
Upcoming SlideShare
Loading in …5
×

Men Against the Beast - from Patient-passive to Patient-active Prostate Cancer Intervention

839 views

Published on

This presentation from 2000 discusses patient activism and government research support for Prostate Cancer.

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Men Against the Beast - from Patient-passive to Patient-active Prostate Cancer Intervention

  1. 1. Men Against the Beast from Patient-passive to Patient-active Prostate Cancer Intervention
  2. 2. THE DREAD: Prostate Cancer in the U.S.A. <ul><li>Affects aproximately 10 million men </li></ul><ul><li>179,300 new cases in 1999 </li></ul><ul><li>37,000 died from PCa in 1999 </li></ul>
  3. 3. Consequences of Treatment: <ul><li>Impotence </li></ul><ul><li>Incontinence </li></ul><ul><li>Loss of Libido </li></ul>
  4. 4. PCa organizations <ul><li>1987: American Foundation for Urologic Disease </li></ul><ul><li>1990: US-TOO </li></ul><ul><li>1993: CaP-CURE </li></ul><ul><li>1994: American Prostate Society </li></ul><ul><li>1996: National Prostate Cancer Coalition </li></ul>
  5. 6. Mortality by type of Cancer and Age <ul><li>Yearly rate per 100.000 persons </li></ul>
  6. 7. Prostate and Breast Cancer Mortality by Year <ul><li>Yearly rate per 100.000 persons </li></ul>
  7. 8. Prostate and Breast Cancer Mortality by Race <ul><li>Yearly rate per 100.000 persons </li></ul>
  8. 9. Impotence Research <ul><li>1982: International Society for Impotence Research </li></ul><ul><li>1989: International Meeting of Andrology </li></ul><ul><li>1990’s: vacuum devices </li></ul><ul><li>1992: NIH Consensus Development Conference on Impotence </li></ul><ul><li>1995: European Society of Impotence Research </li></ul><ul><li>1995: Alprostadil </li></ul><ul><li>1998: Viagra </li></ul>
  9. 10. Scientific Meetings on Prostate Cancer
  10. 11. NCI Appropriations 1980-1999
  11. 12. Compare: NCI Research dollars by type of cancer
  12. 13. Cancer is incurable, but avoidable Cancer is inevitable, but treatable/curable Prevention So let’s work in So let’s work in Treatment/cure Life-style Regulation Regulatory perspective Survivorship perspective

×